posted on 2021-06-10, 17:39authored byThaer S. A. Abdalla, Jan Meiners, Sabine Riethdorf, Alexandra König, Nathaniel Melling, Tobias Gorges, Karl-F. Karstens, Jakob R. Izbicki, Klaus Pantel, Matthias Reeh
Fig (a): Overall survival in patients with CRC, metastatic vs. non-metastatic disease. Fig (b): Progression-free survival in patients with CRC, metastatic vs. non-metastatic disease. P-value Indicates significance according to Log-Rank (Mantel-Cox) test when mCRC is compared to non-mCRC.